CARM
Carisma Therapeutics
CARM
CARM
Delisted
CARM was delisted on the 10th of October, 2025.
29 hedge funds and large institutions have $11.5M invested in Carisma Therapeutics in 2016 Q3 according to their latest regulatory filings, with 12 funds opening new positions, 10 increasing their positions, 2 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
99% less call options, than puts
Call options by funds: $1K | Put options by funds: $93K
Holders
29
Holding in Top 10
1
Calls
$1K
Puts
$93K
Top Buyers
| 1 | +$642K | |
| 2 | +$222K | |
| 3 | +$182K | |
| 4 |
DTL
Dynamic Technology Lab
Singapore
|
+$116K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$101K |
Top Sellers
| 1 | -$700K | |
| 2 | -$198K | |
| 3 | -$75.1K | |
| 4 |
TSS
Two Sigma Securities
New York
|
-$42K |
| 5 |
Bank of Montreal
Toronto,
Ontario, Canada
|
-$25K |